VMV HYPOALLERGENICS ARMADA POST PROCEDURE 50 PLUS

Manufacturer
SKIN SCIENCES LABORATORY INC.
Effective date
2015-09-14
Label type
HUMAN OTC DRUG LABEL
Version
1
Source
full-release
Hydrated at
2026-05-31 22:43:52

Label at a glance#

ProductVMV HYPOALLERGENICS ARMADA POST PROCEDURE 50 PLUS
Active ingredientTITANIUM DIOXIDE, ZINC OXIDE
Label structure6 sections

Indications and uses

- Helps prevent sunburn. - If used as directed with other sun protection measures (see Directions), decrease the risk of skin cancer and early skin aging caused by the sun.

Dosage and administration

- Apply liberally 15 minutes before sun exposure - Use a water resistant sunscreen if swimming or sweating. - Reapply at leats every 2 hours - Sun Proctection Measures. Spending time in the sun increases your risk of skin cancer and early skin aging. To decrease the risk, regularly use a sunscreen with a Broad Spectrum SPF value of 15 or higher and other sun protection measure including: - Limit time in the sun, e...

Label contents#

Full prescribing information#

Uses

INDICATIONS & USAGE SECTION

- Helps prevent sunburn.

- If used as directed with other sun protection measures (see Directions), decrease the risk of skin cancer and early skin aging caused by the sun.

Warnings

WARNINGS SECTION

For External use only

Do not use on damagae skin or broken skin

Stop use and ask doctor if rash occurs

When using this product keep out of eyes. Rinse with water to remove.

Keep out of reach of children, if swallowed, get medical help or contact a Poison Control Center right away.

Directions

INSTRUCTIONS FOR USE SECTION

- Apply liberally 15 minutes before sun exposure

- Use a water resistant sunscreen if swimming or sweating.

- Reapply at leats every 2 hours

- Sun Proctection Measures. Spending time in the sun increases your risk of skin cancer and early skin aging. To decrease the risk, regularly use a sunscreen with a Broad Spectrum SPF value of 15 or higher and other sun protection measure including:

- Limit time in the sun, especiallly from 10am to 2pm

- Wear long-sleeved shirts, pants, hats, and sunglasses.

- Children under 6months: Ask a doctor.

Other Information

INFORMATION FOR PATIENTS SECTION

- Protect the product in this container from excessive heat and direct sun

- Before use, test a tiny amount on skin (we omit allergen, but you may be sensitive to an ingredient that is not an allergen.)

- Introduce new skin products one at a time, with atleast 3 days in between.

- Do not (re)introduce removed portions of products or other substances into container.

Inactive Ingredients

INACTIVE INGREDIENT SECTION

Alumina, Aluminum Stearate, Butylene Glycol, Camellia Sinensis Leaf Extract, Caprylic/Capric Triglyceride, Citric Acid, Cyclopentasiloxane, Ferric Ferrocyanide, Glyceryl Caprate, Glyceryl Laurate, Hydrogen Dimethicone, Iron Oxide, PEG-10 Dimethicone, Polyhydrostearic Acid, Sodium Phytate, Water.

Principal Display Panel

PACKAGE LABEL.PRINCIPAL DISPLAY PANEL

Armada_Post_ProcedureArmada_Post_ProcedureVMV HYPOALLERGENICS

validated hypoallergenics randomized blinded

published & awarded clinical studies since 1979

ARMADA

POST-

PROCEDURE

BARRIER

CREAM

50+

BROAD SPECTRUM SPF 50+

rednedd-reducing barrier cream + indoor-outdoor

mineral sun+light screen

Validated Hypoallergenic:

VH -76/76

sans all common allergens:

extended allergen series North American

Contact Dermatitis Group + standard

allergenc series European Surveillance

System on Contact Allergies

SPF 50+ (70). PFA: 40.

High/Superior UVA/UVB Protection.

BOOTS (3 stars). Critical Wavelength:

378. UVA:UVB Ratio 0.74.

100% All-Types-Of-Fragrance-Free.

100% Dye-Phthalate-Paraben +

Preservative Free.

Usage, Patch + Clinically-Tested

(in-vitro + in-vivo).

Non-Comedogenic. Non-Drying.

30g (1.06 Oz. ) - 30g e

FDA-Initiated Inactive NDC Indexing#

NDC, Effective, Action table
NDCEffectiveActionDocumentIndexing SPLRelated label
69774-163-302020-01-31C16284748780-19d75b9d1-2a09-f424-e053-dadaa90a57ce1fc12db9-6563-509b-e054-00144ff88e88

DailyMed Package Descriptions#

Package NDC, Product, Description table
Package NDCProductDescriptionFormQuantityStrengthSPL version
69774-163-30VMV HYPOALLERGENICS ARMADA POST PROCEDURE 50 PLUS1 in 1 BOXCREAM11
69774-163-30VMV HYPOALLERGENICS ARMADA POST PROCEDURE 50 PLUS30 g in 1 TUBECREAM301

DailyMed Dashboard NDC Coverage#

NDC, Dashboard title, SPL version table
NDCDashboard titleSPL versionValidationDashboard ZIP
69774-163VMV HYPOALLERGENICS ARMADA POST PROCEDURE 50 PLUS (TITANIUM DIOXIDE, ZINC OXIDE,) CREAM [SKIN SCIENCES LABORATORY INC.]1Legacy NDC, 2 package rows20151020_1fc12db9-6563-509b-e054-00144ff88e88.zip

DailyMed Socrata Ingredients#

Ingredient, Type, UNII table
IngredientTypeUNIISPL versionUploaded
TITANIUM DIOXIDEACTIVE INGREDIENT15FIX9V2JP1
ZINC OXIDEACTIVE INGREDIENTSOI2LOH54Z1
TITANIUM DIOXIDEACTIVE MOIETY15FIX9V2JP1
ZINC OXIDEACTIVE MOIETYSOI2LOH54Z1
WATERINACTIVE INGREDIENT059QF0KO0R1

Products#

Every source-derived product name is available through these pages.

DailyMed product names page 1 of 1 · 5 matching rows.

NDC Codes#

Product NDC, Package NDC table
Product NDCPackage NDC
69774-16369774-163-30

Ingredients#

Every source-derived ingredient row is available through these pages.

DailyMed ingredient rows page 1 of 1 · 3 matching rows.

Name, UNII, Kind table
NameUNIIKind
WATER059QF0KO0RIACT
TITANIUM DIOXIDE15FIX9V2JPACTIB
ZINC OXIDESOI2LOH54ZACTIB

Source Document#

Source XML

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
1fc12db9-6564-509b-e054-00144ff88e881fc12db9-6563-509b-e054-00144ff88e882015-09-14WarningsExact identifier
spl id: 1fc12db9-6564-509b-e054-00144ff88e88
spl set id: 1fc12db9-6563-509b-e054-00144ff88e88

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.